September 26, 2018—Madison Memorial Hospital is a 69-bed, county-owned facility in southeastern Idaho that provides needed primary and specialty care for its community without relying on any additional funding from the taxpayers. Part of how it can do that is through the savings it realizes from the 340B program. Dorsie Sullenger, the hospital’s director of pharmacy, notes … [Read more...]
340B Health and Other Groups Sue HHS Challenging Delay of 340B Regulation
September 11, 2018—Today, 340B Health and three other national hospital associations have filed suit to force the U.S. Department of Health and Human Services (HHS) to enforce rules prohibiting manufacturers from overcharging 340B providers. The suit also would compel HHS to post 340B ceiling prices on a secure website. In 2010, Congress responded to a series of reports by … [Read more...]
Writing in The New York Times, Economist Ignores Research Showing 340B Is Working
September 7, 2018—Healthcare economist Austin Frakt recently wrote in The New York Times that the 340B drug discount program includes hospitals “that don’t need the extra help” and don’t use the program to benefit low-income patients. That’s a one-sided view that ignores research showing 340B is working as Congress intended. The research Frakt overlooks includes findings … [Read more...]
Faces of 340B: Lifesaving Care During Disasters
August 23, 2018—Hurricane Harvey made landfall in Texas just over a year ago, dumping more than 40 inches of rain in the Houston metropolitan area. More than 30,000 people were displaced in the resulting floods. It also created a public health crisis that demanded a rapid response. The Centers for Disease Control and Prevention (CDC) recommends that responders to disasters … [Read more...]
New Independent Study Confirms 340B is a Small Share of U.S. Drug Market
August 8, 2018—A new report by independent researchers refutes claims by the pharmaceutical industry that the 340B drug pricing program is so large it forces manufacturers to raise their prices. Writing in the Health Affairs Blog, a team of researchers from the Pew Charitable Trusts found the 340B program is only 1.4 percent of gross U.S. drug sales. This confirms earlier … [Read more...]
New Study on Cancer Care Has Important Implications for 340B
August 7, 2018—Critics of the 340B drug pricing program often claim that the lower cost of drugs for 340B hospitals is driving up the cost of care for cancer patients in hospital outpatient departments. But a new study published in the American Journal of Managed Care (AJMC) shows cancer care spending is actually lower in hospitals when adjusted for the severity of patients’ … [Read more...]
Faces of 340B: Care Close to Home
July 20, 2018 – The last thing that a cancer patient wants to do after receiving a chemotherapy treatment is to get in a car for a long drive home. But that’s exactly what some Nebraska patients would need to do if Johnson County Hospital weren’t able to provide that care locally. “The nearest tertiary hospital is approximately 45 miles to over 100 miles away,” said Olivia … [Read more...]